e-learning
resources
2022
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of
N
-acetyl-
l
-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study
Paola Faverio, Paola Rebora, Emanuela Rossi, Savino Del Giudice, Filippo Montanelli, Laura Garzillo, Sara Busnelli, Fabrizio Luppi, Maria Grazia Valsecchi, Alberto Pesci
Source:
ERJ Open Res, 8 (1) 00542-2021; 10.1183/23120541.00542-2021
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Paola Faverio, Paola Rebora, Emanuela Rossi, Savino Del Giudice, Filippo Montanelli, Laura Garzillo, Sara Busnelli, Fabrizio Luppi, Maria Grazia Valsecchi, Alberto Pesci. Impact of
N
-acetyl-
l
-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study. ERJ Open Res, 8 (1) 00542-2021; 10.1183/23120541.00542-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020
Year: 2020
Risk for asthma following pneumonia in infancy – a nationwide register-based cohort study with family design
Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections
Year: 2020
Psychiatric complications of COVID-19 pneumonia: preliminary results of a single-centre prospective study.
Source: Virtual Congress 2021 – COVID - 19
Year: 2021
Impact of bacteremia in a cohort of predominantly elderly patients with pneumococcal pneumonia. Epidemiologic and case-control study
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002
The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
COVID-19 pneumonia and clinical follow-up: results of a prospective cohort
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021
Thrombocytosis predicts poor outcomes in patients with community-acquired pneumonia: results from the CAPO international cohort study
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Impact of nivolumab-induced fever on the treatment effect: a retrospective study
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019
Long-term effects of severe acute malnutrition on lung function in Malawian children: a cohort study
Source: Eur Respir J , 49 (4) 1601301; DOI: 10.1183/13993003.01301-2016
Year: 2017
Risk of recurrence after surviving severe sepsis: A matched cohort study
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
Assessment of the association between asthma and malignancy: a population-based retrospective matched cohort study
Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases
Year: 2009
Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study
Source: Eur Respir J, 56 (3) 2000767; 10.1183/13993003.00767-2020
Year: 2020
Prolonged effect of air pollution on pneumonia: a nationwide cohort study
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017
Prevalence of severe asthma – results from a population-based study.
Source: International Congress 2019 – Asthma and the world
Year: 2019
Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study
Source: ERJ Open Res, 5 (1) 00014-2019; 10.1183/23120541.00014-2019
Year: 2019
Preliminary results of the pilot pneumonia multicentric study in the GABRIEL network for etiological agents identification
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007
Female gender is associated with poor clinical outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Impact of chronic cough in individuals with COPD: a population-based cohort study
Source: International Congress 2019 – More and more COPD
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept